• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comment to Impact of postmastectomy radiotherapy on the outcomes of breast cancer patients with T1-2 N1 disease; an individual patient data analysis of three clinical trials.

作者信息

Matuschek Christiane, Krug David, Klement Rainer J, Baumann René

机构信息

Klinik für Strahlentherapie und Radioonkologie, Medical Faculty, Universitätsklinikum Düsseldorf, Heinrich-Heine Universität, Moorenstr. 5, 40225, Düsseldorf, Germany.

RadioOnkologie und Strahlentherapie, UniversitätsKlinikum Heidelberg, 69120, Heidelberg, Germany.

出版信息

Strahlenther Onkol. 2019 Apr;195(4):306-307. doi: 10.1007/s00066-018-1411-2.

DOI:10.1007/s00066-018-1411-2
PMID:30610353
Abstract
摘要

相似文献

1
Comment to Impact of postmastectomy radiotherapy on the outcomes of breast cancer patients with T1-2 N1 disease; an individual patient data analysis of three clinical trials.
Strahlenther Onkol. 2019 Apr;195(4):306-307. doi: 10.1007/s00066-018-1411-2.
2
Reply to the letter to the editor "Comment to 'Impact of postmastectomy radiotherapy on the outcomes of breast cancer patients with T1-2 N1 disease; an individual patient data analysis of three clinical trials'".
Strahlenther Onkol. 2019 Apr;195(4):308-309. doi: 10.1007/s00066-019-01433-w.
3
Impact of postmastectomy radiotherapy on the outcomes of breast cancer patients with T1-2 N1 disease : An individual patient data analysis of three clinical trials.术后放疗对 T1-2N1 期乳腺癌患者结局的影响：三项临床试验的个体患者数据分析。
Strahlenther Onkol. 2019 Apr;195(4):297-305. doi: 10.1007/s00066-018-1343-x. Epub 2018 Aug 1.
4
Outcome of postmastectomy radiotherapy after primary systemic treatment in patients with clinical T1-2N1 breast cancer.临床T1-2N1期乳腺癌患者在接受初次全身治疗后进行乳房切除术后放疗的结果。
Cancer Radiother. 2018 Feb;22(1):38-44. doi: 10.1016/j.canrad.2017.07.051. Epub 2018 Jan 3.
5
The Role of Postmastectomy Radiation Therapy in Patients With Breast Cancer Responding to Neoadjuvant Chemotherapy.乳房切除术后放射治疗在对新辅助化疗有反应的乳腺癌患者中的作用。
Semin Radiat Oncol. 2016 Jan;26(1):51-8. doi: 10.1016/j.semradonc.2015.08.001. Epub 2015 Aug 29.
6
Intrinsic subtypes and benefit from postmastectomy radiotherapy in node-positive premenopausal breast cancer patients who received adjuvant chemotherapy - results from two independent randomized trials.接受辅助化疗的淋巴结阳性绝经前乳腺癌患者的内在亚型及乳房切除术后放疗的获益——两项独立随机试验的结果
Acta Oncol. 2018 Jan;57(1):38-43. doi: 10.1080/0284186X.2017.1401735. Epub 2017 Nov 25.
7
Overview of randomized trials in high risk breast cancer patients treated with adjuvant systemic therapy with or without postmastectomy irradiation.
Semin Radiat Oncol. 1999 Jul;9(3):292-9. doi: 10.1016/s1053-4296(99)80022-8.
8
[The role of postmastectomy radiotherapy in clinical T1-3N1M0 breast cancer patients with pathological negative lymph nodes after neoadjuvant chemotherapy and mastectomy].新辅助化疗及乳房切除术后病理淋巴结阴性的临床T1-3N1M0乳腺癌患者乳房切除术后放疗的作用
Zhonghua Zhong Liu Za Zhi. 2017 Jun 23;39(6):445-452. doi: 10.3760/cma.j.issn.0253-3766.2017.06.009.
9
Comparison of clinical outcome of breast cancer patients with T1-2 tumor and one to three positive nodes with or without postmastectomy radiation therapy.比较 T1-2 期肿瘤和 1-3 个阳性淋巴结的乳腺癌患者在接受或不接受乳腺癌根治术后放疗的临床结局。
Jpn J Clin Oncol. 2012 Aug;42(8):711-20. doi: 10.1093/jjco/hys080. Epub 2012 May 29.
10
Locally advanced breast cancer and postmastectomy radiotherapy.局部晚期乳腺癌与乳房切除术后放疗
Surg Oncol Clin N Am. 2000 Jul;9(3):603-20, x-xi.

引用本文的文献

1
Impact of Adjuvant Radiation Therapy in Patients With Male Breast Cancer: A Multicenter International Analysis.辅助放疗对男性乳腺癌患者的影响：一项多中心国际分析。
Adv Radiat Oncol. 2020 Feb 20;5(3):345-349. doi: 10.1016/j.adro.2020.01.006. eCollection 2020 May-Jun.

本文引用的文献

1
Impact of postmastectomy radiotherapy on the outcomes of breast cancer patients with T1-2 N1 disease : An individual patient data analysis of three clinical trials.术后放疗对 T1-2N1 期乳腺癌患者结局的影响：三项临床试验的个体患者数据分析。
Strahlenther Onkol. 2019 Apr;195(4):297-305. doi: 10.1007/s00066-018-1343-x. Epub 2018 Aug 1.
2
Impact of smoking history on the outcomes of women with early-stage breast cancer: a secondary analysis of a randomized study.吸烟史对早期乳腺癌女性结局的影响：一项随机研究的二次分析。
Med Oncol. 2018 Apr 11;35(5):68. doi: 10.1007/s12032-018-1129-0.
3
Adjuvant radiation therapy of regional lymph nodes in breast cancer - a meta-analysis of randomized trials- an update.
乳腺癌区域淋巴结的辅助放疗——随机试验的荟萃分析——更新版
Radiat Oncol. 2015 Dec 21;10:258. doi: 10.1186/s13014-015-0568-4.
4
Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer.乳腺癌内乳和锁骨上内侧照射。
N Engl J Med. 2015 Jul 23;373(4):317-27. doi: 10.1056/NEJMoa1415369.
5
Regional Nodal Irradiation in Early-Stage Breast Cancer.早期乳腺癌的区域淋巴结照射
N Engl J Med. 2015 Jul 23;373(4):307-16. doi: 10.1056/NEJMoa1415340.
6
Locoregional recurrence risk for patients with T1,2 breast cancer with 1-3 positive lymph nodes treated with mastectomy and systemic treatment.T1、2 期乳腺癌伴 1-3 个阳性淋巴结患者行乳房切除术和全身治疗后的局部区域复发风险。
Int J Radiat Oncol Biol Phys. 2014 Jun 1;89(2):392-8. doi: 10.1016/j.ijrobp.2014.02.013. Epub 2014 Apr 7.
7
Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials.**译文**： **术后放疗对乳腺癌复发和 20 年死亡率的影响：22 项随机试验 8135 名患者个体数据的荟萃分析**
Lancet. 2014 Jun 21;383(9935):2127-35. doi: 10.1016/S0140-6736(14)60488-8. Epub 2014 Mar 19.
8
Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial.辅助多西他赛、多柔比星和环磷酰胺治疗淋巴结阳性乳腺癌：III 期随机 BCIRG 001 试验的 10 年随访结果。
Lancet Oncol. 2013 Jan;14(1):72-80. doi: 10.1016/S1470-2045(12)70525-9. Epub 2012 Dec 12.
9
Prognostic and predictive value of TP53 mutations in node-positive breast cancer patients treated with anthracycline- or anthracycline/taxane-based adjuvant therapy: results from the BIG 02-98 phase III trial.TP53 基因突变对接受蒽环类或蒽环类/紫杉类辅助治疗的淋巴结阳性乳腺癌患者的预后和预测价值：来自 BIG 02-98 期 III 临床试验的结果。
Breast Cancer Res. 2012 May 2;14(3):R70. doi: 10.1186/bcr3179.
10
Phase III study of doxorubicin/cyclophosphamide with concomitant versus sequential docetaxel as adjuvant treatment in patients with human epidermal growth factor receptor 2-normal, node-positive breast cancer: BCIRG-005 trial.多柔比星/环磷酰胺联合序贯多西他赛与单纯多柔比星/环磷酰胺作为人表皮生长因子受体 2 阴性、淋巴结阳性乳腺癌辅助治疗的 III 期研究：BCIRG-005 试验。
J Clin Oncol. 2011 Oct 10;29(29):3877-84. doi: 10.1200/JCO.2010.28.5437. Epub 2011 Sep 12.